What are the side effects of fezolinetant?
Fezolinetant is a non-hormonal drug that is considered safe because it does not act on estrogen receptors. However, like all prescription drugs, it may also cause certain adverse reactions. According to post-marketing data from overseas drug regulatory agencies (such as the U.S. Food and Drug AdministrationFDA), common side effects of fazonatant are mainly concentrated in changes in liver function, gastrointestinal reactions and mild neurological discomfort.
Some patients may experience mild headache, fatigue, or nausea during the initial period of use. These symptoms are usually temporary and gradually lessen as the body adapts to the drug. Individual patients may experience mild elevations in liver enzymes, and doctors will recommend regular monitoring of liver function indicators before and during medication when prescribing. Once symptoms such as persistent fatigue, jaundice, or loss of appetite occur, you should contact your doctor for evaluation in a timely manner. In addition, a small number of people may experience mild diarrhea or stomach discomfort, which is related to the drug's effect on central temperature regulation and digestive system nerves.
It is worth noting that the advantage of filzonitant is that it avoids the risks of hormone replacement therapy, such as breast sensitivity, uterine bleeding or risk of blood clots. Therefore, it has unique value in menopausal women who cannot tolerate or have contraindications to hormone therapy. Most patients tolerate it well with regular use, and adverse effects are mild and reversible.
Judging from usage experience, regular testing of liver function and avoiding simultaneous use with drugs that potentially affect liver metabolism are the keys to ensuring the safety of fezonatan. Overall, fizonatant improves menopausal symptoms, improves sleep and quality of life, has a low incidence of side effects, and mainly mild and controllable symptoms. It is a relatively safe non-hormonal treatment option.
Reference materials:https://www.veozah.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)